stockrowMedpace Holdings, Inc.
MEDP Healthcare Diagnostics & Research
Medpace Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 20.0% from fiscal 2024.
- Revenue
- +8.50%
- EPS
- +24.6%
- Free cash flow
- −16.6%
Quarter to September 2026, against a year earlier
Follow MEDP
Alert me
Medpace Holdings, Inc. (MEDP) Free cash flow
Medpace Holdings, Inc.'s free cash flow for fiscal 2025 was $681.9M, up 19.2% from $572.3M in fiscal 2024. Over the twelve months to 30 September 2026 it was $667.6M. Over the past ten years it has ranged from $78.2M (fiscal 2016) to $681.9M (fiscal 2025) — the current reading is the highest in ten years. Free cash flow has risen for 9 consecutive fiscal years. Medpace Holdings, Inc. ranks 11th of 49 Diagnostics & Research companies by free cash flow.
Free cash flow, annual
Embed this chart
Annual newest first
| Period | Free cash flow | Change |
|---|---|---|
| FY2025 | $681.9M | 19.15% |
| FY2024 | $572.3M | 44.25% |
| FY2023 | $396.7M | 12.97% |
| FY2022 | $351.2M | 49.40% |
| FY2021 | $235.1M | 3.40% |
| FY2020 | $227.3M | 23.58% |
| FY2019 | $184.0M | 30.87% |
| FY2018 | $140.6M | 65.19% |
| FY2017 | $85.1M | 8.82% |
| FY2016 | $78.2M | (1.52%) |
Quarterly newest first
| Period | Free cash flow | Change |
|---|---|---|
| Sep 2026 | $196.4M | 42.24% |
| Jun 2026 | $138.1M | (4.74%) |
| Mar 2026 | $145.0M | (22.93%) |
| Dec 2025 | $188.1M | (20.12%) |
| 41 more quarters | Free account |
Against its own ten years
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| DGX Quest Diagnostics Incorporated compare | $1.4B |
| LH Labcorp Holdings Inc. compare | $1.3B |
| ILMN Illumina, Inc. compare | $1.1B |
| ICLR ICON PLC compare | $857.1M |
| MEDP Medpace Holdings, Inc. | $667.6M |
| RVTY Revvity Inc. compare | $602.5M |
| QGEN QIAGEN N.V. compare | $440.6M |
| CRL Charles River Laboratories International, Inc. compare | $399.6M |
| GH Guardant Health, Inc. compare | −$232.1M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)
More on MEDP
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement